Loading…

Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes

The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in...

Full description

Saved in:
Bibliographic Details
Published in:Endocrine Journal 2014, Vol.61(2), pp.149-157
Main Authors: Saisho, Yoshifumi, Tanaka, Kumiko, Abe, Takayuki, Kawai, Toshihide, Itoh, Hiroshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3
cites cdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3
container_end_page 157
container_issue 2
container_start_page 149
container_title Endocrine Journal
container_volume 61
creator Saisho, Yoshifumi
Tanaka, Kumiko
Abe, Takayuki
Kawai, Toshihide
Itoh, Hiroshi
description The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P
doi_str_mv 10.1507/endocrj.EJ13-0376
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1504141889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1504141889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</originalsourceid><addsrcrecordid>eNo9kcFu3CAQhlHVqtmkfYBeKo69OGUAe82xitI00Uq9tGcLw3jNyjYuYEX7Dn3oYu3WF0A_3_yamZ-QT8DuoWT7rzhZb8Lp_vEFRMHEvnpDdiBkXchSsrdkxxTURa1KdUNuYzwxJkQpxXtywyUHXtewI38P_hUDbTFpanAYaLdMJjk_0YCDThhp8jQuMWk3oaW9O_YZPw5nkz8t1UO7jG5aoU3rcfTHwbdZDjpb0fx40bOeMCKds4JTivTVpZ6m84yUU-t0bgDjB_Ku00PEj9f7jvz-_vjr4Udx-Pn0_PDtUBip6lQAADetZZWoDBNlV7FOdChlC6yylZAGQCkjuRXcmLJTbF8JpTlk1ACWVtyRLxffOfg_C8bUjC6u0-ce_RKbvFwJEupaZRQuqAk-xoBdMwc36nBugK3cvrmG0KwhNGsIuebz1X5pR7Rbxf-tZ-DpApzyXo-4ATokZwbcLCto-Hps1htheh0yJv4BpzGgXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504141889</pqid></control><display><type>article</type><title>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</title><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) - Open Access English articles</source><creator>Saisho, Yoshifumi ; Tanaka, Kumiko ; Abe, Takayuki ; Kawai, Toshihide ; Itoh, Hiroshi</creator><creatorcontrib>Saisho, Yoshifumi ; Tanaka, Kumiko ; Abe, Takayuki ; Kawai, Toshihide ; Itoh, Hiroshi</creatorcontrib><description>The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P &lt;0.001). When the patients were divided into two groups according to median PCPRI, patients with low PCPRI showed higher GA/HbA1c both at baseline and after 2 years compared to those with high PCPRI. There was a significant negative correlation between PCPRI and GA/HbA1c after 2 years (r = -0.379, P &lt;0.001). Multiple regression analysis revealed that PCPRI was an independent predictor of GA/HbA1c after 2 years. In conclusion, our findings suggest that lower beta cell function is associated with sustained higher GA/HbA1c ratio in patients with type 2 diabetes.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.EJ13-0376</identifier><identifier>PMID: 24212881</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Aged ; Asian Continental Ancestry Group ; Beta cell function ; C-peptide ; C-Peptide - blood ; Diabetes Mellitus, Type 2 - physiopathology ; Female ; Glycated albumin ; Glycated hemoglobin ; Glycated Hemoglobin A - metabolism ; Humans ; Insulin-Secreting Cells - physiology ; Male ; Middle Aged ; Regression Analysis ; Retrospective Studies ; Serum Albumin - metabolism ; Type 2 diabetes</subject><ispartof>Endocrine Journal, 2014, Vol.61(2), pp.149-157</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</citedby><cites>FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1875,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24212881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saisho, Yoshifumi</creatorcontrib><creatorcontrib>Tanaka, Kumiko</creatorcontrib><creatorcontrib>Abe, Takayuki</creatorcontrib><creatorcontrib>Kawai, Toshihide</creatorcontrib><creatorcontrib>Itoh, Hiroshi</creatorcontrib><title>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</title><title>Endocrine Journal</title><addtitle>Endocr J</addtitle><description>The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P &lt;0.001). When the patients were divided into two groups according to median PCPRI, patients with low PCPRI showed higher GA/HbA1c both at baseline and after 2 years compared to those with high PCPRI. There was a significant negative correlation between PCPRI and GA/HbA1c after 2 years (r = -0.379, P &lt;0.001). Multiple regression analysis revealed that PCPRI was an independent predictor of GA/HbA1c after 2 years. In conclusion, our findings suggest that lower beta cell function is associated with sustained higher GA/HbA1c ratio in patients with type 2 diabetes.</description><subject>Aged</subject><subject>Asian Continental Ancestry Group</subject><subject>Beta cell function</subject><subject>C-peptide</subject><subject>C-Peptide - blood</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Female</subject><subject>Glycated albumin</subject><subject>Glycated hemoglobin</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Insulin-Secreting Cells - physiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Regression Analysis</subject><subject>Retrospective Studies</subject><subject>Serum Albumin - metabolism</subject><subject>Type 2 diabetes</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kcFu3CAQhlHVqtmkfYBeKo69OGUAe82xitI00Uq9tGcLw3jNyjYuYEX7Dn3oYu3WF0A_3_yamZ-QT8DuoWT7rzhZb8Lp_vEFRMHEvnpDdiBkXchSsrdkxxTURa1KdUNuYzwxJkQpxXtywyUHXtewI38P_hUDbTFpanAYaLdMJjk_0YCDThhp8jQuMWk3oaW9O_YZPw5nkz8t1UO7jG5aoU3rcfTHwbdZDjpb0fx40bOeMCKds4JTivTVpZ6m84yUU-t0bgDjB_Ku00PEj9f7jvz-_vjr4Udx-Pn0_PDtUBip6lQAADetZZWoDBNlV7FOdChlC6yylZAGQCkjuRXcmLJTbF8JpTlk1ACWVtyRLxffOfg_C8bUjC6u0-ce_RKbvFwJEupaZRQuqAk-xoBdMwc36nBugK3cvrmG0KwhNGsIuebz1X5pR7Rbxf-tZ-DpApzyXo-4ATokZwbcLCto-Hps1htheh0yJv4BpzGgXA</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Saisho, Yoshifumi</creator><creator>Tanaka, Kumiko</creator><creator>Abe, Takayuki</creator><creator>Kawai, Toshihide</creator><creator>Itoh, Hiroshi</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2014</creationdate><title>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</title><author>Saisho, Yoshifumi ; Tanaka, Kumiko ; Abe, Takayuki ; Kawai, Toshihide ; Itoh, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Asian Continental Ancestry Group</topic><topic>Beta cell function</topic><topic>C-peptide</topic><topic>C-Peptide - blood</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Female</topic><topic>Glycated albumin</topic><topic>Glycated hemoglobin</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Insulin-Secreting Cells - physiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Regression Analysis</topic><topic>Retrospective Studies</topic><topic>Serum Albumin - metabolism</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saisho, Yoshifumi</creatorcontrib><creatorcontrib>Tanaka, Kumiko</creatorcontrib><creatorcontrib>Abe, Takayuki</creatorcontrib><creatorcontrib>Kawai, Toshihide</creatorcontrib><creatorcontrib>Itoh, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saisho, Yoshifumi</au><au>Tanaka, Kumiko</au><au>Abe, Takayuki</au><au>Kawai, Toshihide</au><au>Itoh, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes</atitle><jtitle>Endocrine Journal</jtitle><addtitle>Endocr J</addtitle><date>2014</date><risdate>2014</risdate><volume>61</volume><issue>2</issue><spage>149</spage><epage>157</epage><pages>149-157</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>The aim of this study was to clarify the relationship between baseline beta cell function and future glycated albumin (GA) to glycated hemoglobin ratio (GA/HbA1c) in patients with type 2 diabetes. In our retrospective cohort, 210 type 2 diabetic patients who had been admitted to our hospital and in whom HbA1c and GA had been measured at baseline and 2 years after admission were included in this study. Baseline beta cell function was assessed by postprandial C-peptide immunoreactivity index (PCPRI) during admission. With intensification of treatment during admission, HbA1c and GA were significantly decreased 1 year and 2 years after admission. While baseline HbA1c was not significantly correlated with HbA1c after 2 years, baseline GA/HbA1c was strongly correlated with GA/HbA1c after 2 years (r = 0.575, P &lt;0.001). When the patients were divided into two groups according to median PCPRI, patients with low PCPRI showed higher GA/HbA1c both at baseline and after 2 years compared to those with high PCPRI. There was a significant negative correlation between PCPRI and GA/HbA1c after 2 years (r = -0.379, P &lt;0.001). Multiple regression analysis revealed that PCPRI was an independent predictor of GA/HbA1c after 2 years. In conclusion, our findings suggest that lower beta cell function is associated with sustained higher GA/HbA1c ratio in patients with type 2 diabetes.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>24212881</pmid><doi>10.1507/endocrj.EJ13-0376</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 2014, Vol.61(2), pp.149-157
issn 0918-8959
1348-4540
language eng
recordid cdi_proquest_miscellaneous_1504141889
source J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - Open Access English articles
subjects Aged
Asian Continental Ancestry Group
Beta cell function
C-peptide
C-Peptide - blood
Diabetes Mellitus, Type 2 - physiopathology
Female
Glycated albumin
Glycated hemoglobin
Glycated Hemoglobin A - metabolism
Humans
Insulin-Secreting Cells - physiology
Male
Middle Aged
Regression Analysis
Retrospective Studies
Serum Albumin - metabolism
Type 2 diabetes
title Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A14%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lower%20beta%20cell%20function%20relates%20to%20sustained%20higher%20glycated%20albumin%20to%20glycated%20hemoglobin%20ratio%20in%20Japanese%20patients%20with%20type%202%20diabetes&rft.jtitle=Endocrine%20Journal&rft.au=Saisho,%20Yoshifumi&rft.date=2014&rft.volume=61&rft.issue=2&rft.spage=149&rft.epage=157&rft.pages=149-157&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.EJ13-0376&rft_dat=%3Cproquest_cross%3E1504141889%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c498t-1112cbd0636c035f60f3fe44b106d634c1199c42d32cc5f907639a2135fc1e5d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1504141889&rft_id=info:pmid/24212881&rfr_iscdi=true